Hardean E. Achneck
Corporate Officer/Principal bei The European Society of Cardiology
Aktive Positionen von Hardean E. Achneck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The European Society of Cardiology | Corporate Officer/Principal | - | - |
| The International Society of Thrombosis & Hemostasis | Corporate Officer/Principal | - | - |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Corporate Officer/Principal | - | - |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | - | - |
Karriereverlauf von Hardean E. Achneck
Ehemalige bekannte Positionen von Hardean E. Achneck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22.02.2019 | 01.06.2022 |
| HEMOSTEMIX INC. | Geschäftsführer | - | - |
| Technik-/Wissenschafts-/F&E-Leiter | 28.03.2016 | 31.07.2016 |
Ausbildung von Hardean E. Achneck
| Yale University | Undergraduate Degree |
| Yale School of Medicine | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
| Frankreich | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| HEMOSTEMIX INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
| The European Society of Cardiology | |
| The International Society of Thrombosis & Hemostasis | |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
- Börse
- Insiders
- Hardean E. Achneck
- Erfahrung
